Centers | ||
|
|
|
test | Therapeutic Accelerator Program (TAP) | EU-OPENSCREEN |
sfgd |
Test |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
Partnerships |
Events |
Jobs |
Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage ObesityAstra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage obesity, control glucose and lipid metabolism in... View all Senex BiotechnologyThe mission of Senex Biotechnology is to discover and develop therapeutic agents to effectively treat cancer, viral diseases and age-related diseases, such as Alzheimer's, renal disease, atherosclerosis, and arthritis, by targeting damage-inducible... View all Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes SpaceSanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. Scientists from both groups will be... View all |
No EVENTS for listing |
No Job Posts |
